Despite the central role PSD-95 plays in anchoring postsynaptic AMPARs, how PSD-95 itself is tethered to postsynaptic sites is not well understood. Here we show that the F-actin binding protein a-actinin binds to the very N terminus of PSD-95. Knockdown (KD) of a-actinin phenocopies KD of PSD-95. Mutating lysine at position 10 or lysine at position 11 of PSD-95 to glutamate, or glutamate at position 53 or glutamate and aspartate at positions 213 and 217 of a-actinin, respectively, to lysine impairs, in parallel, PSD-95 binding to a-actinin and postsynaptic localization of PSD-95 and AMPARs. These experiments identify a-actinin as a critical PSD-95 anchor tethering the AMPAR-PSD-95 complex to postsynaptic sites.
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In Brief Matt et al. introduce a-actinin as a critical postsynaptic docking protein for PSD-95 and AMPARs. They found that disruption of the PSD-95-a-actinin interaction by point-mutating the essential residues on either protein leads to reduced synaptic localization of PSD-95 and AMPARs. 
INTRODUCTION
The vast majority of synapses in the brain are glutamatergic (Micheva et al., 2010) . Postsynaptic AMPA-type glutamate receptors (AMPARs) have to be precisely juxtaposed to presynaptic release sites for fast and efficient synaptic transmission (Tang et al., 2016; Sinnen et al., 2017) . The localization of postsynaptic AMPAR critically depends on PSD-95 (El-Husseini et al., 2000 Elias et al., 2006; Schl€ uter et al., 2006) . PSD-95 consists of three PDZ domains followed by an SH3 domain and a guanylate kinase homology domain (GK; Figure 1A ). Through its first and second PDZ domains, PSD-95 recruits AMPARs to postsynaptic sites by interacting with the intracellular C termini of auxiliary subunits, known as transmembrane AMPAR regulatory proteins (TARPs), including stargazin (Stg, g 2 ) and its homologs g 3 , g 4 , and g 8 (Chen et al., 2000; Opazo et al., 2010; Schnell et al., 2002) . Palmitoylation of Cys3 and Cys5 near the N terminus of PSD-95 is critical for its postsynaptic accumulation, which, in turn, is important for postsynaptic targeting of AMPARs (El-Husseini et al., 2002; Fukata et al., 2013) . The palmitoyl acyltransferase (PAT) DHHC2 accumulates at postsynaptic sites when basal neuronal activity is reduced. This DHHC2 accumulation leads to an increase in PSD-95 palmitoylation, especially at postsynaptic sites (Noritake et al., 2009 ). Thus, palmitoylation that is localized to postsynaptic sites augments postsynaptic PSD-95 targeting. However, other PATs, including DHHC3, which is mostly associated with the Golgi apparatus rather than with postsynaptic sites, also contribute to postsynaptic localization of PSD-95 (Fukata et al., 2013; Noritake et al., 2009) , and palmitoylation is not a tagging mechanism that would specifically anchor proteins at the postsynaptic plasma membrane but is a rather general mechanism for association with membranes. For instance, palmitoylation of the postsynaptic A kinase anchor protein AKAP150 preferentially targets it to endosomes rather than the plasma membrane (Woolfrey et al., 2015) . Which proteins function to specifically anchor and stabilize PSD-95 at the postsynaptic plasma membrane is largely unknown, despite the identification of many PSD-95-interacting proteins (Sheng and Kim, 2011) . For example, GK-domain-associated proteins (GKAPs) bind to the PSD-95 GK domain (Kim et al., 1997) , linking PSD-95 to Shank and, thereby, Homer and cortactin, the latter binding to F-actin Tu et al., 1999) . Although GKAP up-and downregulation affected synaptic transmission accordingly, it is unclear whether GKAP exerted these effects by interacting with PSD-95 (Shin et al., 2012) . Similarly, Shank1 knockout decreased synapse density, size, and strength, but the mechanism of this change is unknown (Hung et al., 2008) . Recent evidence now suggests that ephrin-B3 is a postsynaptic anchoring protein for PSD-95 (Hruska et al., 2015) . PSD-95 can bind to the cytosolic C terminus of this integral plasma membrane protein, and the point mutations L293A and S332D in the C terminus of ephrin-B3 impair PSD-95 binding and postsynaptic localization of PSD-95 and also of ephrin-B3 itself. However, L293A also affects ERK1/2 binding, whereas S332 is an extracellular signal-related kinase (ERK) phosphorylation site. Therefore, it is unclear whether these mutations reduce postsynaptic PSD-95 by decreasing its binding to ephrin-B3 or indirectly, possibly by altering ERK signaling. In fact, the decrease in postsynaptic PSD-95 anchoring seen upon ephrin-B3 knockdown can be rescued by pharmacological inhibition of mitogen-activated protein kinase kinase (MEK)-ERK signaling. This finding indicates that there must be another postsynaptic protein that can anchor PSD-95 independent of the presence of ephrin-B3. In addition, it is unclear how abundant ephrin-B3 is and how well it is stoichiometrically matched with the highly abundant PSD-95. The postsynaptic abundance of AMPARs defines synaptic strength, which is usually stable at basal activity levels but can persistently be altered by heightened activity patterns that induce long-term potentiation (LTP) and long-term depression (LTD) (Huganir and Nicoll, 2013) . LTP and LTD are thought to be important mechanisms for storage of information during learning and memory formation (Morris, 2013; Whitlock et al., 2006) . Related forms of synaptic plasticity underlie different brain pathologies such as posttraumatic stress disorder (PTSD; Clem and Huganir, 2010) and drug addiction (Wolf and Tseng, 2012) . AMPAR dysfunction and dysregulation also contribute to numerous diseases of the brain, such as depression (Skolnick et al., 2009) , autism (Ebert and Greenberg, 2013; Etherton et al., 2011) , epilepsy (McNamara et al., 2006) , and stroke-induced neuronal damage (Liu et al., 2004; Noh et al., 2005) . Thus, understanding the mechanisms that determine postsynaptic AMPAR localization and function is of high relevance.
Here we identify a-actinin as a major postsynaptic anchoring protein for PSD-95. a-Actinin is best known for cross-linking F-actin and for anchoring F-actin to cell-cell and cell-matrix junctions (Foley and Young, 2014; Otey and Carpen, 2004; Sjö blom et al., 2008) . Overexpression as well as knockdown (KD) of a-actinin affects spine density and structure (Hodges et al., 2014; Hoe et al., 2009; Kalinowska et al., 2015; Nakagawa et al., 2004) . We now report that a-actinin binds to the very N terminus of PSD-95, thereby stabilizing it at postsynaptic locations. Systematic extensive KD, rescue, and point mutation experiments unequivocally demonstrate a central role of a-actinin in postsynaptic localization of PSD-95 and, thereby, of AMPARs.
RESULTS

a-Actinin Is Associated with PSD-95
We recently identified a-actinin as the critical anchoring protein for the L-type Ca 2+ channel Ca v 1.2 in dendritic spines (Hall et al., 2013) . Therefore, and because of its prominent enrichment in spines (Wyszynski et al., 1998) and postsynaptic densities (PSDs; Racz and Weinberg, 2004; Walikonis et al., 2000) , we evaluated whether a-actinin is involved in anchoring PSD-95 and, in turn, AMPARs. We immunoprecipitated PSD-95 and probed immunoblots (IBs) with a pan-specific antibody against a-actinin. The four isoforms encoded by the four different a-actinin genes have a nearly identical relative molecular mass (M R ; Sjö blom et al., 2008) and migrate as a single band on SDS-PAGE (Figure 1B, lysate; Hall et al., 2013) . This band was present in PSD-95 but not control immunoglobulin G (IgG) immunoprecipitates.
To investigate whether a-actinin specifically interacts with PSD-95 or perhaps also with one or more of the less abundant PSD-95 homologs PSD-93, SAP97, and SAP102, we first established a set of antibodies that specifically recognize one of each of these four proteins. Each antibody detected distinct bands in brain lysate of the approximated M R ( Figure 1C ; note that SAP97 runs as a doublet at $120 kDa, which is often not resolved; Valtschanoff et al., 2000) , with PSD-95 showing three different bands that are due to differential splicing and posttranslational modification such as palmitoylation, as described previously (ElHusseini et al., 2000 (ElHusseini et al., , 2002 Schl€ uter et al., 2006; Topinka and Bredt, 1998) . The specificity of each antibody was confirmed by IB after immunoprecipitation (IP) of each individual PSD-95 homolog, the IP only isolating the respective immunoreactive protein bands that were recognized by the individual antibody in total lysate ( Figure 1D ), as well as by IB of purified glutathione S-transferase (GST)-tagged proteins ( Figure S1A ). The additional band for PSD-93 in the IP lane and the broad main band likely reflect the existence of six or more splice variants (Kr€ uger et al., 2013; Parker et al., 2004) . Remarkably, co-immunoprecipitation (coIP) of a-actinin was only observed with PSD-95 ( Figure 1D , bottom).
a-Actinin CH1, CH2, and EF Domains Interact with the N Terminus of PSD-95 To assess the possibility of a direct interaction between PSD-95 and a-actinin, domains of PSD-95 ( Figure 1A) were expressed in E. coli as GST fusion proteins and immobilized on glutathione Sepharose beads for use in pull-down assays. Of those, only the fragment consisting of the N-terminal 64 residues, PDZ1, Figure 1 . a-Actinin-1 CH1, CH2, and EF-Hand Domains Interact with PSD-95 (A) Schematic of PSD-95 and a-actinin domain structure. Horizontal lines, pull-down constructs. (B) Co-immunoprecipitation (coIP) of a-actinin (pan antibody) with PSD-95 (JH62092) from Triton X-100 brain lysates. (C) Immunoblots (IBs) of total brain lysates identify specific bands for PSD-93, PSD-95, SAP97, and SAP102 (all antibodies from NeuroMAB). (D) IP of PSD-93, PSD-95, SAP97, and SAP102 from Triton X-100 brain lysates yielded the respective IB band(s) without cross-reactivity or coIP among PSD-95 homologs. Pan a-actinin co-immunoprecipitated only with PSD-95. (E) Top left: pull-down of MBP-tagged a-actinin-1 by GST-tagged PSD-95 domains (see A) detected by IB with anti-MBP. Bottom left: IB with anti-GST indicates that comparable amounts of the PSD-95 fusion proteins were present. Right: densitometric analysis of MBP intensities shows significantly stronger binding of a-actinin-1 to the N-terminal portion of PSD-95 (NT-PDZ1/2) than any other construct (n = 6). (F) Top left: pull-down of MBP-tagged a-actinin domains but not MBP alone by immobilized PSD-95 NT-PDZ1/2. Bottom left: IB with anti-GST indicates that comparable amounts of PSD-95 NT-PDZ1/2 were present in all samples. Right: densitometric MBP quantification (n = 8).
(G) Top left: pull-down of MBP-tagged a-actinin CH1 and CH2 domains but not MBP alone by PSD-95 NT-PDZ1/2. Bottom left: comparable amounts of PSD-95 NT-PDZ1/2 were present in all samples. Right: densitometric quantification (n = 4). (H) Summary IB run with equal amount of sample as for (F) and (G) illustrates that comparable amounts of the MBP-tagged a-actinin constructs were present. (I) Top left: pull-down of the MBP-tagged a-actinin EF region with (EF) and without the last 4 residues that bind PDZ domains (EF-DPDZ) but not of MBP alone by PSD-95 NT-PDZ1/2. Bottom left: comparable amounts of PSD-95 NT-PDZ1/2 were present in all samples. Right: Densitometric MBP quantification (n = 8). Statistical significance was tested by one-way ANOVA with Dunnett's multiple comparisons test. All bar graphs are presented as the means ± SEM. See Table S1 for values. See also Figure S1 . and PDZ2 domains (NT-PDZ1/2) robustly and consistently pulled down recombinant full-length a-actinin-1 fused to maltose binding protein (MBP; Figure 1E , top left), confirming a specific and direct interaction between the two proteins. PSD-95 NT-PDZ1/2 pulled down MBP-tagged CH1/2, SR3, and EF-hand of a-actinin-1 ( Figure 1F ) and individual CH1 and CH2 domains ( Figure 1G ). The additional lower-weight band observed for MBP-tagged constructs is due to limited proteolysis of a fraction of the isolated protein. Similar quantities of all MBP-tagged a-actinin-1 domains were used in pull-down experiments ( Figure 1H ). PSD-95 NT-PDZ1/2 also pulled down the EF-hand domain lacking the C-terminal PDZ ligand residues ESDL (EF-DPDZ; Kim and Sheng, 2004; Walikonis et al., 2001; Xia et al., 1997) , indicating that binding between the EF-hand and PDZ-1/2 is not mediated by a PDZ interaction ( Figure 1I ). Similar results were obtained with full-length GST-PSD-95 (Figures S1B-S1D). A GST construct containing only the first 71 residues of PSD-95, which are N-terminal to PDZ1, was equally effective in pulling down CH1, CH2, CH1/2, SR3, EF, and EF-DPDZ domains ( Figure S1E ), identifying the N terminus of PSD-95 as a binding site for different a-actinin domains.
KD of a-Actinin Reduces Synapse Density but Not Structure We previously developed four short hairpin RNAs (shRNAs), each of which specifically knocks down one of the four a-actinins (Hall et al., 2013; Schnizler et al., 2009 ). Neurons express a-actinin-1, -2, and -4 but not -3 (Hall et al., 2013; Nakagawa et al., 2004; Schnizler et al., 2009; Wyszynski et al., 1998; L.M. and J.W.H., unpublished data) . We transfected hippocampal cultures with a parental vector as a control or a combination of shRNA-expressing vectors against a-actinin-1, -2, and -4 to knock down all three isoforms (KD124). An a-actinin-1 construct rendered shRNAinsensitive by silent mutations (rescue; Hall et al., 2013) served as control for the specificity of the KD. A validated shRNA against a-actinin-3 (KD3; Hall et al., 2013; Schnizler et al., 2009 ) constituted an additional control to rule out side effects of transfection per se with a hairpin-forming shRNA. Sholl analysis did not reveal any effect on dendritic arborization ( Figure S2A ). KD124 did, however, lead to an $40% reduction in the density of spines (Figure S2G) and immunofluorescence of (IF) puncta for all synaptic proteins we studied (a-actinin, bassoon, F-actin, GluA1, GluA2, GluN1, PSD-93, PSD-95, SAP97, SAP102, Shank, and synapsin; Figures 2 and S3 ). KD124 decreased not only a-actinin punctum density but also intensity by $50% versus the vector control (Figure 2A) , illustrating a-actinin KD. Accordingly, KD124 not only reduced synapse numbers but also the a-actinin content of the remaining synapses by half. Remarkably, a morphometric study of individual spines did not show any detectable changes in the size, shape, or normal distribution of types upon KD124 ( Figures  S2C-S2F ). This finding was somewhat surprising because a-actinin is an effective F-actin crosslinking protein (Sjö blom et al., 2008) and is highly enriched at postsynaptic sites (Racz and Weinberg, 2004; Walikonis et al., 2000; Wyszynski et al., 1998) . In support of the lack of a profound effect on postsynaptic structure by KD124, the punctum intensity of F-actin staining with fluorescently labeled phalloidin ( Figure 2C ) or of IF of Shank did not change either upon KD124 ( Figure S3B ). The punctum intensity of the presynaptic markers synapsin ( Figure 2A ) and bassoon ( Figure S3A ) was also unaltered by KD124, indicating that postsynaptic a-actinin KD does not affect presynaptic structures.
a-Actinin KD Reduces Postsynaptic PSD-95 but Not AMPAR or NMDAR Content Mirroring its effect on a-actinin, KD124 also reduced the IF punctum intensity of PSD-95 by 50% but had no effect on PSD-93, SAP102, or SAP97 ( Figures 2B, 2D , 2F, and 2G). The intensity of surface staining for the prevalent AMPAR subunits GluA1 (GluA1 EC ; Figure 2B ) and GluA2 (GluA2 EC ; Figure 2D ) and obligatory N-methyl-D-aspartate receptor (NMDAR) subunit GluN1 (GluN1 EC ; Figure 2E ) was minimally, if at all, affected in synapses that survived KD124. Consistently, KD124 reduced the frequency but not amplitude of miniature excitatory postsynaptic currents (mini EPSCs [mEPSCs]; Figure S3C ). These findings show that a-actinin KD phenocopies PSD-95 KD and knockout, which also led to a reduction in synapse number with unaltered AMPAR content in the remaining synapses (Bé ïque et al., 2006; Ehrlich et al., 2007; Elias et al., 2006; Levy et al., 2015; Discussion) . Primary rat hippocampal neuronal cultures were transfected at 4 days in vitro (DIV), fixed, and stained at 18 DIV. Parental pSilencer vectors encoding EGFP and KD3 served as controls. a-Actinin-1, -2, and -4 were knocked down with specific shRNAs (KD124), whereas shRNA-insensitive a-actinin-1* was co-expressed for rescue of KD124. Representative images for each synaptic protein examined are shown on the left. The bar diagrams on the right represent quantifications of the density and mean intensity (in a.u.) of immunofluorescent puncta.
(A) The punctum density of a-actinin and synapsin was reduced by KD124. The punctum intensity of a-actinin (but not synapsin) was reduced by KD124 (n > 50 images from > 25 cells from five independent experiments).
(B) The punctum density of PSD-95 and extracellular GluA1 EC IF was reduced by KD124. The punctum intensity of PSD-95 was reduced by $50% by KD124.
GluA1
EC showed a small, non-significant reduction (n > 33 images from > 16 cells from three independent experiments).
(C) The punctum density but not intensity of F-actin staining with Alexa 555-labeled phalloidin was reduced by KD124 (n > 33 images from > 16 cells from four independent experiments).
(D) The punctum density but not intensity of PSD-93 and extracellular GluA2 EC IF was reduced by KD124 (n > 36 images of > 18 cells from six independent experiments).
(E) The punctum density but not intensity of extracellular GluN1 EC IF was reduced by KD124 (n > 35 images of > 17 cells from four independent experiments).
(F) The punctum density but not intensity of SAP102 was reduced by KD124 (n > 34 images of > 17 cells from three independent experiments).
(G) The puncta density of SAP97 was insignificantly reduced by KD124. The punctum intensity of SAP97 was not affected by KD124 (n > 19 images of > 9 cells from three independent experiments). Statistical significance was tested by one-way ANOVA with Bonferroni's multiple comparisons test. All bar graphs are presented as the means ± SEM. See Table S2 Full length α-actinin-2 ) were titrated with increasing amounts of a-actinin-1 (Zhang et al., 2014) . Only the peptide spanning residues 1-13 displayed saturable binding ( Figure 3B ). Peptide 1-13 also showed saturable binding to CH1/2 and EF but not the SR3 domain of a-actinin-1 ( Figure 3C ). GST fusion proteins of fulllength and N-terminal fragments of PSD-95 pulled down the MBP-tagged SR3 domain of a-actinin but not MBP alone (Figures 1F and S1B and S1E) . To reconcile the negative peptide and positive pull-down data, we loaded glutathione Sepharose with plain GST, which pulled down MBP-SR3 but not MBP alone ( Figure S1F ). Accordingly, the MBP-tagged SR3 domain binds to GST alone, and this interaction does not reflect SR3 binding to PSD-95. Neither full-length MBP-a-actinin nor its CH1, CH2, and EF domains bound to GST alone, confirming the specificity of their PSD-95 interactions ( Figure S1F ). Peptide 1-13 but not 15-36 could competitively prevent coIP of a-actinin with PSD-95 from brain lysate ( Figure 3D ). Thus, this peptide mimics the binding site on PSD-95 for a-actinin. a-Actinin could also be displaced from PSD-95 by the N-terminal 64 residues of PSD-95. Accordingly, PSD-95 residues 1-13 constitute the physiologically relevant binding site for a-actinin, whose interaction with PSD-95 is mediated by its CH1/2 or EF domain or both.
Lys10 and Lys11 of PSD-95 Are Necessary for a-Actinin Binding Binding of a-actinin-1 and -2 and the CH1/2 domain of a-actinin-1 in overlay assays to spot synthesized peptide arrays of 13-residue-long peptides shifted through the N terminus of PSD-95 ( Figure 3E ) was weakened as T9 (peptide 11) and lost as K10 (peptide 12) were shifted out of the peptide. Consistently, a triple alanine scan of peptide 1-13 showed the strongest reduction in CH1/2 binding when K10 or K11 was altered ( Figure 3F ). Scanning peptide 1-13 by replacing individual residues with glutamate for titration with MBP-a-actinin showed that binding was only slightly affected when T8, T9, Y12, or R13 was changed (T8E, T9E, Y12E, and R13E), whereas changing K10 or K11 (K10E, K11E, KK10, and 11EE) resulted in a strong reduction in binding ( Figure 3G ). All of these mutations affected Ca Figure S5A ). Accordingly, these mutations did not affect postsynaptic PSD-95 binding through a palmitoylationrelated mechanism but, rather, by decreasing a-actinin binding ( Figure 3G ).
a-Actinin Binding-Deficient PSD-95 Fails to Promote Postsynaptic AMPAR Accumulation PSD-95 KD reduces the mEPSC frequency but not amplitude of surviving synapses (Ehrlich et al., 2007; Elias et al., 2006) because of homeostatic mechanisms that allow functionally surviving synapses to maintain a full AMPAR quota when most other synapses lose all AMPARs (Levy et al., 2015 ; see also Bian et al., 2015) . The engagement of those homeostatic mechanisms complicates the interpretation of PSD-95 KD effects. On the other hand, overexpressed PSD-95 WT accumulates in the postsynaptic site and increases not only the number of AMPAR-containing Figure S5G ), GluA1 EC punctum density and intensity ( Figure 5A ), and mEPSC frequency and amplitude ( Figure 5B ). Strikingly, overexpression of all a-actinin binding-deficient mutants failed completely to increase spine density ( Figure S5G ), GluA1 EC punctum density and intensity ( Figure 5A ), and mEPSC frequency and amplitude ( Figure 5B ). Again in accordance with previously published data (Ehrlich and Malinow, 2004; El-Husseini et al., 2000) , overexpression of WT and mutant PSD-95 did not affect GluN1 punctum density and intensity, except for a modest decrease in punctum intensity upon overexpression of PSD-95 K11E and PSD-95 K10,11EE
( Figure 5C ).
PSD-95
Residue K10 Interacts with E213 and D217 in CH2 and K11 with E53 in CH1 To identify residues in a-actinin that bind to K10 and K11 in PSD-95, we generated a structural model ( Figure 6A ) by docking our published structure of the first 19 residues of the PSD-95 N terminus (Zhang et al., 2014) to a published structure of the CH1/2 domain of a-actinin-1 (PDB: 2EYI; Borrego-Diaz et al., 2006) using the program HADDOCK (de Vries et al., 2010) . This model predicted that PSD-95 residue K10 interacts with E213 and D217 in CH2 and K11 with E53 in CH1, respectively. To test this prediction, we mutated the negatively charged E53 or E213 and D217 in MBP-tagged CH1/CH2 to positively charged lysine (CH1/2 E53K and CH1/2 ED213,217KK ). As with full-length a-actinin-1 (Figure 3G) , titration of N-terminal PSD-95 peptides with MBP-tagged WT CH1/CH2 showed decreased affinity for 1-13 K10E , 1-13
K11E
, and 1-13 KK10,11EE versus WT peptide 1-13 ( Figure S6A ). Importantly, the affinity for WT peptide 1-13 was strongly reduced for MBP-tagged CH1/2 E53K and CH1/2 ED213,217KK ( Figure S6B ). Pull-down experiments of purified WT and mutant full-length MBP-a-actinin-1 with purified full-length WT and mutant GST-PSD-95 confirmed that the E53K and ED213,217KK point mutations in a-actinin-1 as well as the K10E and K11E point mutations in PSD-95 strongly impaired the binding ( Figure S6C ).
Molecular Replacement of a-Actinin with a-Actinin-1 Deficient in PSD-95 Binding Impairs Postsynaptic PSD-95 and AMPAR Targeting We created full-length shRNA-insensitive a-actinin-1* E53K and a-actinin-1* ED213,217KK for a KD replacement approach because simple overexpression of a-actinin in neurons leads to a number of well documented morphological defects (Hodges et al., 2014; Hoe et al., 2009; Kalinowska et al., 2015; Nakagawa et al., 2004 ; P.-Y. Tseng and J.W.H., unpublished data). Co-transfection of our combined sh124 plasmids to KD a-actinin-1, -2, and -4 with shRNA-insensitive a-actinin-1* WT allowed for rescue with substantial but not complete replacement of endogenous a-actinin in cultured neurons (Figure 2 ). Co-transfection with a-actinin-1* E53K (E53K) or a-actinin-1* ED213,217KK (ED_KK), however, resulted in an $50% reduction in IF signal intensity of endogenous PSD-95 and GluA2, in PSD-95 spine enrichment, and in the density of GluA2-positive puncta ( Figures 6B-6F ). The point mutations did not affect the total levels of PSD-95 ( Figure S6D ) or a-actinin ( Figure S6E ). There was, however, a modest but statistically significant reduction in spine levels for a-actinin-1* E53K but not for a-actinin-1* ED213,217KK ( Figure S6F ). Because this reduction could affect F-actin content and, therefore, have indirect effects on PSD-95 localization, we quantified F-actin after labeling with phalloidin by stimulated emission depletion (STED) microscopy. Importantly, neither a-actinin-1* E53K nor a-actinin-1*
affected F-actin content in spines ( Figures S6G and S6H ).
Molecular Replacement of PSD-95 with a-Actinin-1 Binding-Deficient PSD-95 Impairs Postsynaptic PSD-95 and AMPAR Targeting We performed analogous molecular replacement experiments with PSD-95 using an established KD/rescue plasmid (Schl€ uter et al., 2006) . The shRNA strongly decreased endogenous PSD-95, and IB indicated that ectopically expressed GFP-PSD-95 matched the level of endogenous PSD-95 in untransfected neurons (Chowdhury et al., 2018) . Furthermore, IF analysis indicated that total PSD-95 levels, and specifically the levels of ectopically expressed GFP-PSD-95, were comparable between WT and mutant PSD-95 isoforms ( Figure S6I ). Importantly, PSD-95 replacement with GFP-PSD-95 K10E as well as GFP-PSD-95
showed an $50% decrease in spine intensity and enrichment for GFP-PSD-95 signals ( Figures 6G-6I ) as well as sGluA2 spine intensity and punctum density ( Figures 6G, 6J , and 6K). /CaM and, thus, prevents re-palmitoylation of PSD-95 (Zhang et al., 2014) . Given that a-actinin also binds to the first 13 residues of PSD-95, we hypothesized that Ca Figure 3D , right lane). Most remarkably, treatment of forebrain slices with NMDA nearly abolished coIP of a-actinin with PSD-95 (Figure 7) . In parallel, coIP of CaM with PSD-95 was strongly increased. Both of these effects were blocked by three structurally different CaM antagonists (Figure 7 ).
DISCUSSION
Collectively, our biochemical, cell biological, and electrophysiological data clearly demonstrate that K10 and K11 in the Figure 4 , fixed, and stained at 18 DIV for extracellular GluA1 (GluA1 EC ) (A) or, after permeabilization, total GluN1 (GluN1 total ) (C) or used for mEPSC recordings at 11-14 DIV (B). Mean IF intensities (right bar diagrams) were quantified as above.
(A) All three PSD-95 mutations abrogated the increase in GluA1 EC punctum density and intensity induced by ectopic PSD-95 WT expression (n > 12 images from > 6 cells from three independent experiments).
(B) mEPSC sample traces (left) and averaged individual events from a single cell (right) to scale (top) and normalized to peak (bottom). All three PSD-95 mutations abrogated the increase in frequency and amplitude induced by ectopic PSD-95 WT expression. The average mEPSC decay time was unchanged (n = 5-9 cells per condition). . n > 18 images from two independent cultures. Statistical significance was tested by Kruskal-Wallis test followed by Mann-Whitney U test with Bonferroni correction. All bar graphs are presented as the means ± SEM. See Table S5 for values. See also Figure S6 .
PSD-95 N terminus are critical for a-actinin binding and postsynaptic targeting of PSD-95 and AMPARs. Two different point mutations on PSD-95 independently affect a-actinin binding and postsynaptic PSD-95 and AMPAR accumulation upon both overexpression and its molecular replacement. Moreover, complementary analysis of two point mutations in a-actinin-1 that impaired PSD-95 binding showed analogous results with molecular a-actinin replacement experiments.
The postsynaptic content for the PSD-95 homologs PSD-93, SAP97, and SAP102 is not affected by a-actinin KD when PSD-95 is reduced by $50% (Figure 2) . Given that SAP97, SAP102, and four of the six known N-terminal splice variants of PSD-93 (Kr€ uger et al., 2013; Parker et al., 2004) do not contain sequences that are homologous to the N-terminal 13 residues of PSD-95, those PSD-95 homologs must be postsynaptically anchored in a way different from PSD-95 and apparently independent of a-actinin. In fact, although coIP of a-actinin with PSD-95 was prominent, no such coIP was detectable for PSD-93, SAP97, or SAP102 ( Figure 1D ).
Notably, a-actinin KD did not overtly affect AMPARs or NMDARs at surviving synapses, as indicated by surface labeling of GluA1, GluA2, and GluN1 and mEPSC analysis. This finding provides further strong evidence for a-actinin's role as a PSD-95 docking protein because it phenocopies the remarkable effect of PSD-95 KD that similarly results in a comparable (40%) decrease of functional synapses, with surviving synapses maintaining their full AMPAR and NMDAR activity (Elias et al., 2006; Levy et al., 2015) . Although a compensatory upregulation of PSD-93, SAP97, or SAP102, which contributes to postsynaptic AMPAR and NMDAR targeting (Bé ïque et al., 2006; Ehrlich et al., 2007; Elias et al., 2006; Levy et al., 2015; Schl€ uter et al., 2006) , is not detectable by our IF labeling following a-actinin-1/-2/-4 KD ( Figures 2F and 2G) , it would have been conceivable that each of these proteins experiences a small 5%-10% increase, which could mediate a good portion of compensation. Arguing against compensation of loss of PSD-95 upon a-actinin-1/-2/-4 KD by PSD-93, SAP97, and SAP102, combined KD of PSD-95, PSD-93, and SAP102 results in synapses that maintain full strength even in SAP97 knockout neurons, although PSD-95/93/102 KD did not completely remove all protein (Levy et al., 2015) .
In contrast to plain a-actinin KD (Figure 2A ), molecular a-actinin replacement by KD combined with rescue by shRNAresistant a-actinin-1 results in a clear reduction in postsynaptic GluA2 for E53K and E213K/D217K mutant a-actinin ( Figures  6B, 6E , and 6F). Plain KD reduces a-actinin by 46% in surviving spines, which is well matched by the 39% reduction in PSD-95 content in spines ( Figure 2B ). Upon plain KD, the remaining a-actinin is all WT and competent to bind postsynaptic PSD-95, which, in turn, anchors postsynaptic AMPARs. Upon replacement, the remaining endogenous a-actinin is diluted out by recombinant a-actinin. Accordingly, in addition to the reduction in endogenous a-actinin, which is PSD-95 bindingcompetent, ectopically expressed a-actinin that is PSD-95 Statistical significance was tested by one-way ANOVA with Dunnett's multiple comparisons test. All bar graphs are presented as the means ± SEM. See Table S6 for values. See also Figure S7 .
binding-impaired dilutes out the remaining endogenous a-actinin. As a result, the decrease in postsynaptic PSD-95 is larger (52% rather than 39%) than upon simple a-actinin KD, and a reduction in postsynaptic GluA2 localization becomes obvious when molecular replacement a-actinin was used rather than simple KD. Of note, we do see a 25% reduction in postsynaptic GluA1 content upon plain a-actinin KD, although this reduction did not reach statistical significance ( Figure 2B ). In addition, one needs to take into account that NMDARs and some other postsynaptic proteins have a much higher affinity for the PDZ domains of PSD-95 than TARPs (Lim et al., 2002; Zhu et al., 2016) . Thus, NMDARs and other proteins will tie up a substantial pool of PSD-95 before PSD-95 is available for AMPAR/TARP anchoring. This notion is reflected by the observation that KD of PSD-95, PSD-93, or SAP102 only affects postsynaptic AMPAR and not NMDAR responses (Elias et al., 2006; Schl€ uter et al., 2006) unless all three of these membrane-associated guanylate kinases (MAGUKs) are knocked down or eliminated otherwise (Elias et al., 2008; Levy et al., 2015) . Maintenance of the strength of surviving synapses after PSD-95 KD depended on L-type Ca 2+ channels and calcium/ calmodulin-dependent protein kinase kinase (CaMKK)/CaMKIV signaling (Levy et al., 2015) . Inhibition of this signaling cascade resulted in a nearly normal number of functionally active synapses but at much reduced strength. A similar mechanism that allows some synapses to survive with full strength and eliminates most of the others is likely at work in our a-actinin-1/-2/-4 KD experiments. a-Actinin-1/-2/-4 KD also reduces Ca v 1.2 in spines (Hall et al., 2013) . However, this reduction was only 25%, and, thus, 75% of it is maintained.
How does a-actinin link PSD-95 to postsynaptic sites? F-actin determines spine size, which is correlated with PSD size (Harris and Stevens, 1989) and, therefore, AMPAR content (Takumi et al., 1999) and synaptic strength (Matsuzaki et al., 2001 ). In the most parsimonious model, F-actin content and, therefore, spine size translates into a-actinin/PSD-95/AMPAR docking to F-actin. In fact, it appears that the bulk of spine a-actinin is docked to F-actin because dissociation of F-actin also reduces synaptic a-actinin (Allison et al., 2000) , and the bulk of both a-actinin and F-actin is in the spine interior (Korobova and Svitkina, 2010; Racz and Weinberg, 2004) . However, we are not convinced that F-actin is the main docking site for the a-actinin subpopulation that anchors PSD-95 because dissociation of F-actin reduces postsynaptic PSD-95 modestly but postsynaptic a-actinin strongly (Allison et al., 2000) . In addition, AMPAR anchoring is only one of many a-actinin functions likely mediated by a rather small subpopulation of a-actinin. We rather favor a model whereby a-actinin links PSD-95 at postsynaptic sites to other critical organizers of the PSD. In fact, there is a clear zone of modest enrichment of a-actinin immediately cytosolic to the PSD (Racz and Weinberg, 2004) , and a-actinin has been detected multiple times in PSD preparations (e.g., Peng et al., 2004) . a-Actinin also binds to other postsynaptic proteins, including NMDARs, densin 180, and CaMKII (Merrill et al., 2007; Robison et al., 2005; Walikonis et al., 2001; Wyszynski et al., 1998) , all of which could participate in anchoring PSD-95 via a-actinin under various conditions. In addition, a-actinin is linked to cadherin via a-and b-catenin (Nieset et al., 1997) . Cadherin promotes postsynaptic strength (Tai et al., 2008) and growth of individual spines at the cost of their neighbors (Bian et al., 2015) , which could explain how PSD-95 KD and a-actinin-1/-2/-4 KD strongly reduce synapse number but not strength. A synapse with a small advantage with respect to activity might augment its strength by diverting postsynaptic building blocks, including AMPARs, from neighboring spines. Ca 2+ influx triggers postsynaptic displacement of PSD-95 by inducing Ca 2+ /CaM binding to the depalmitoylated N terminus of PSD-95, preventing re-palmitoylation (Zhang et al., 2014) . We now show that NMDA-induced Ca 2+ influx also disrupts the association of PSD-95 with a-actinin in a Ca 2+ /CaM-dependent manner (Figure 7 ). Consistent with a competitive mechanism, the N-terminal PSD-95 1-13 peptides K10E and K11E exhibit impaired binding of both a-actinin and Ca CaM to the PSD-95 N terminus antagonizes two key mechanisms of regulating postsynaptic PSD-95 anchoring, palmitoylation, and association with a-actinin ( Figure S7 ). The PSD-95 mutation E17R impairs binding of Ca 2+ /CaM to PSD-95 (Chowdhury et al., 2018) . This mutation abrogates LTD (Xu et al., 2008) as well as homeostatic synaptic downscaling during increased network activity (Chowdhury et al., 2018) . Accordingly, displacement of PSD-95 by Ca 2+ /CaM from a-actinin as described for the first time here is a central molecular event in homeostatic downscaling and LTD.
STAR+METHODS
Detailed methods are provided in the online version of this paper and include the following: 
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DNA Constructs
All recombinant DNA used in this study is listed in STAR Methods and Table S11 . Maltose binding protein (MBP) tagged a-actinin domains CH1/2 (residues 1-262), CH1 (1-139), CH2 (140-262), SR1 (263-388), SR2 (389-504), SR3 (505-624), SR4 (625-739), EF (740-892), EF-DPDZ (740-888) were generated like previously described for MBP-tagged full-length a-actinin-1 and -2 (Hall et al., 2013) . In brief, required domains were PCR-amplified with oligonucleotide primers containing EcoRI and HindIII sites (all oligonucleotides used in this study are listed in STAR Methods and Table 10 ). The PCR-products were digested and ligated into pMalE-c2 (NEB) using EcoRI and HindIII. GST-tagged PSD-95 domains N-term (residues 1-71), NT-PDZ1/2 (1-248), PDZ2 (156-248), PDZ3 (302-402), SH3 (431-500), and GK (534-724) were previously described (Joiner et al., 2010; Seabold et al., 2003; Zhang et al., 2014) . GST-tagged full-length PSD-95 and SAP97 were kind gifts from C.C. Garner (M€ uller et al., 1996; Wu et al., 2000) . Full-length Mus musculus PSD-93a cDNA was a kind gift from Morgan Sheng, and was cloned in frame into the EcoRI restriction site of pGEX-4T1. To correct for the missing N-terminal 133 amino acids in the SAP102-GST construct (Leonard et al., 1998) , we subcloned a 2.1 kb BamHI fragment from the full-length SAP102 pCMV (an expression construct obtained from C.C. Garner) into the 7.5 kb BamHI fragment of the truncated SAP102-GST construct. All GST tags are located at the N terminus of the fusion proteins. Full-length calmodulin (Zhang et al., 2014) consists of Xenopus calmodulin cDNA inserted in pET3a (no tag). The Xenopus calmodulin amino acid sequence is identical to that of vertebrate calmodulins (Chien and Dawid 1984) .
Small hairpin RNAs targeting a-actinin isoforms 1 through 4 in pSilencer 1.0-Ub6 (Ambion) were previously described (Schnizler et al., 2009) .
To replace dsRed with eGFP, the CMV-eGFP cassette from pEGFP (Clontech) was PCR-amplified with oligonucleotide primers containing KpnI sites and ligated into the respective KpnI-digested pSilencer vectors.
The previously described (Hall et al., 2013) shRNA-insensitive rescue a-actinin-1* was modified to remove superfluous residues from the C terminus by PCR-amplification of the C-terminal part of the cDNA with a reverse primer containing a stop codon and an EcoRI restriction site. The PCR product was cloned back into the original template using EcoRI and SbfI resulting in a shRNAinsensitive a-actinin-1 cDNA featuring the original C-terminal sequence (ESDL).
RFP-tagged PSD-95 (PSD-95 WT ) was previously described (Zhang et al., 2014) . Briefly, PSD-95 cDNA (gratefully received from David Bredt, UCSF) was first inserted into pEGFP using HindIII and EcoRI and subsequently shuttled into pTagRFP-N (Evrogen, Moscow, Russia) using NheI and KpnI restriction sites. Mutated a-actinin and PSD-95 constructs were created with complementary mutagenic nucleotides for PCR amplification of the whole plasmid using Q5 high-fidelity DNA polymerase (NEB) and subsequent digestion with DpnI to remove non-mutated, methylated template DNA before transformation of the nicked PCR-product into NEB 5-alpha competent E. coli.
PSD-95 lacking the first 64 residues (PSD-95 D64) was created by PCR-amplification using a forward-priming oligonucleotide to introduce an NheI restriction site and new start codon. The PCR product was cloned back into the original template using NheI and EcoNI.
Lentivial transfer vector construct (FHUG+W) expressing shRNA against PSD-95 and shRNA-insensitive rescue PSD-95 (with eGFP fused to its C terminus; Schl€ uter et al., 2006) was kindly provided by Drs. O. M. Schl€ uter and R. C. Malenka. To generate lentiviral construct expressing rescue PSD-95 containing K10E or K11E mutation, the N terminus of PSD-95 in FHUG+W vector was removed by digestion with XbaI (5 0 external)/BsmBI (internal), and corresponding region containing mutation generated by digestion with Nhe/BsmBI from pTagRFP was ligated into FHUG+W construct.
Immunoprecipitation and Immunoblotting
All procedures were previously described in detail (Hall et al., 2006; Hell et al., 1993; Zhang et al., 2014) . In brief, 1 g adult rat brain was homogenized in 10 mL ice-cold buffer A (in mM; 150 NaCl, 10 HEPES, 10 EDTA, 10 EGTA, pH 7.4) containing protease inhibitors (in mg/ml; 1 phenylmethanesulfonyl fluoride, 1 pepstatin A, 10 leupeptin, 20 aprotinin) and 1% Triton X-100 with a glass-teflon homogenizer. The homogenate was cleared by ultracentrifugation for 30 min at 250,000 x g. A Bicinchoninic Acid (BCA) plate assay (Thermo Scientific) was used to measure protein concentration. 1 mg of dissolved protein was incubated with 1 mg antibody (JH62092, a-actinin (pan), PSD-93, PSD-95, SAP97, SAP102, or non-immune IgG control) and 20 ml protein G-Sepharose beads (GE Healthcare) for 4 h at 4 C under tilting before washing 3 times at 4 C in buffer A containing protease inhibitors as above and 1% Triton X-100, extraction with SDS sample buffer at 95 C for 5 min, separation by electrophoresis in 7.5% polyacrylamide gels, transfer to polyvinylidene fluoride (PVDF) membranes, probing with the indicated primary antibodies, and detection with secondary, horseradish peroxidase-coupled antibodies. Immunosignals were visualized using chemiluminescent peroxidase substrate (Merck Millipore) and photographic film (Denville). Multiple exposures ensured linear range of the signals which were quantified through densitometry using Photoshop CS3 software (Adobe; Hall et al., 2006) .
In Vitro Pull-Down Assays Expression and purification of GST fusion proteins (Hall et al., 2007; Leonard et al., 1998; Lim et al., 2002) and MBP fusion proteins (Hall et al., 2013; Merrill et al., 2007) from BL21(DE3) E. coli (NEB) was performed as cited (all recombinant proteins used in this study are listed in STAR Methods and Table S9 ). Briefly, transformed bacteria were incubated in 500 mL medium at 37 C until reaching an OD 600 of 1 and then induced for 2-4 h with 100 mM IPTG. Bacteria were harvested by centrifugation and lysed first by incubation with 0.1 mg/ml lysozyme in 50 mL TBS (150 mM NaCl, 15 mM Tris-Cl, pH 7.4) before sonication and, for GST fusion proteins, by addition of 1.5% Sarcosyl, which was neutralized by addition of one volume TBS and Triton X-100 to a final concentration of 4%. Insoluble material was removed by centrifugation. For purification, 100 mL GST fusion protein extracts were bound to 2 mL glutathione Sepharose 4B (Amersham) and 50 mL MBP fusion protein to 2 mL amylose resin (NEB), washed with 100 column volumes TBS containing 0.1% Triton X-100 (TBS-T), and eluted with 10-15 mM glutathione and 10 mM maltose, respectively. For pull down assays, one partner (0.1-1 mL lysate) was immobilized on the respective resin (30 ml), washed three times with TBS-T, incubation with purified binding partners for 90-120 min at 4 C in TBS-T, and washed tree times with TBS-T before immunoblotting with anti-GST or anti-MBP antibodies. For re-probing, PVDF membranes were stripped with SDS and dithiothreitol (Hall et al., 2013; Leonard et al., 1998) .
Fluorescence Polarization Assays
Synthetic peptides with N-terminal fluorescein label were purchased from ChinaPeptides (all synthetic peptides used in this study are listed in STAR Methods and Table S8 ). 100 nM peptide was added to multiple aliquots of 50 ml FP buffer (in mM; 50 HEPES, pH 7.4, 100 KCl, 1 MgCl 2 , 0.05 EGTA, 5 mM nitrilotriacetic acid) in 96-well black polystyrene plates (Corning) for titration with increasing amounts of purified recombinant proteins. Raw FP values were determined with a Synergy 2 plate reader (BioTek) with 485/20l excitation and 528/20l emission filters using the manufacturer's proprietary Gen5 software. Data were analyzed in GraphPad Prism as described (Lim et al., 2002) . For each titration the strongest signal was normalized to 100% after subtraction of baseline.
Peptide Array PEG-cellulose SPOT Synthesis Peptide Arrays were obtained from the Biopolymers & Proteomics Laboratory at MIT. Membranes with peptides were blocked with 10% milk powder in TBS (TBS-M), incubated with MBP fusion proteins (see above) in TBS-M, and washed with TBS. Bound fusion proteins were electrophoretically transferred onto PVDF membranes, which were probed with the anti-MBP antibody.
Primary Embryonic Hippocampal Cultures
Dissociated hippocampal cells were prepared as follows (Chen et al., 2014; Zhang et al., 2014) . Hippocampi from E18 embryonic rats of both sexes (Sprague-Dawley, Charles River Laboratories) were treated with 0.03% trypsin (Sigma) in Hank's balanced salt solution (HBSS; Life Technologies) for 10 min at 37 C. After inactivation of trypsin with neuronal medium (NeuralQ basal medium (GlobalStem) supplemented with NS21 (Chen et al., 2008) , 0.5 mM glutamine, 10 mM HEPES, 1 mM sodium pyruvate) plus 2.5% Horse serum (HS; Gemini), the tissue was washed twice with HBSS, and triturated with a fire-polished Pasteur pipette. After non-dissociated pieces of tissue settled, cells in the supernatant were collected by centrifugation (200 x g, 3.5 min), re-suspended in neuronal medium plus 2.5% HS, counted, and plated on coverslips (Warner Instruments) coated with 0.1% (w/v) poly-L-lysine at a cell density of 3 3 10 4 cm
À2
. After 4 h, the medium was replaced with serum-free neuronal medium. Cells were grown in a humidified environment with 5% CO 2 at 37 C. One third of the medium was changed after 5 days in vitro (DIV) and weekly thereafter. Transfection was performed at 4 DIV using Lipofectamine 2000 (Life Technologies) or calcium phosphate at 7 DIV.
Virus Preparation and Infection
For production of lentivirus, the transfer vector, the HIV-1 packaging vector expressing gag and pol, and the VSVG envelope glycoprotein vector were cotransfected into HEK293 cells using the calcium phosphate method. Culture media collected at 48 and 72 hours after transfection was centrifuged at 64,000 x g to concentrate virus. Dissociated hippocampal neurons were infected with lentivirus at 10 DIV and fixed after 8 days.
Immunofluorescence 18 DIV neurons were fixed in PBS containing 4% paraformaldehyde (PFA) and 4% (w/v) sucrose at room temperature (RT) for 5 min, washed 3 3 5 min with PBS before permeablilization for 10 min with 0.25% Triton X-100 in PBS at RT. Cells were subsequently washed 3 3 5 min in washing buffer (PBS, 0.01% Triton X-100), and incubated with blocking solution (PBS containing 50 mM NH 4 Cl, 2% glycerol, 2% normal goat serum (Jackson ImmunoResearch), 5% fetal bovine serum (Atlanta Biologicals)) for 2 h at RT before primary antibodies were applied in blocking solution overnight at 4 C. After washing 2 3 5 min and 1 3 15 min in washing buffer, cells were incubated in blocking solution for 45 min at RT before secondary antibodies were applied in blocking solution for 2 h at RT. After washing 2 3 5 min and 1 3 15 min with washing buffer, 1 3 5min with PBS, and 2 3 5 min with H 2 O, coverslips were mounted onto microscope slides with Permafluor (Thermo Fisher).
To stain for surface epitopes, the following additional steps were performed before permeabilization: Coverslips were incubated in blocking solution for 2 h at RT before primary antibodies against extracellular epitopes were applied in blocking solution for 36 h at 4 C. After washing 2 3 5 min and 1 3 15 min in PBS, cells were subjected to a second fixation step with 4% PFA and 4% (w/v) sucrose in PBS for 5 min at RT. Cells were then washed 3 3 5 min with PBS before the staining was continued as described above.
For visualization of F-actin in STED microscopy ( Figure S6G ), coverslips were incubated in PBS containing Alexa488-conjugated phalloidin (Invitrogen, 1:20) for 30 min at RT before mounted onto microscope slides with Prolong Gold Antifade Reagent (Invitrogen).
Imaging
See STAR Methods and Table S12 for all combinations of fluorescent probes used in this study. Images for the Sholl analysis of a-actinin KD ( Figure S2 ) and the initial screening of PSD-95 mutants ( Figure S4 ) were taken using an IX-70 inverted microscope from Olympus (Shinjuku, Japan) with fluorescent optics and a cooled CCD camera (Hammamatsu) controlled by Metamorph software (Molecular Devices). Objective lenses were a 100x / 1.35 NA and a 10x / 0.25 NA for Sholl analysis. Within one experiment, the same exposure time was kept constant for all images from one channel.
For analysis of a-actinin KD (Figures 2 and S2 and S3 ) and the expression of mutant PSD-95 and a-actinin-1 (Figures 4, 5, 6 , and S5), images were taken using a Zeiss LSM 700 confocal laser scanning microscope controlled by Zeiss Zen software using a 100x / 1.3 NA objective lens and 512 3 512 pixel resolution. For all images within an experiment, laser output (below 10%) and detector gain (below 850) were kept at a constant level within the detector's dynamic range. Pinhole diameter was set to 1 Airy unit for the 639 nm laser while pinhole diameters for the 405 nm, 488 nm, and 555 nm lasers were set to conserve optical slice thickness. The slice thickness was optimized by the manufacturer's software (usually around 0.3 mm) to accommodate the selected Z-range. Images were acquired as Z stacks (4-8 optical sections).
STED images of F-actin ( Figure S6G ) were obtained with a Leica TCS SP8 STED 3X microscope using a 100x HC PL APO CS2 oil immersion objective lens (1.4 NA) with 1248 3 1248 resolution. F-actin was visualized with Alexa488-conjugated phalloidin using 499 nm excitation and 592 nm STED depletion laser. DsRed fill from pSilencer vector was used to visualize spine shape using 554 nm excitation.
Image Analysis
Characterization of a-actinin KD Image quantification was performed by a sample blinded operator in ImageJ (Schneider et al., 2012 ) using custom macros. At least 6 images were used for every condition from a minimum of 3 independent experiments. For analysis, two segments of dendrite (typically 30 -60 mm long) were cropped from every image and their length was measured using ImageJ's segmented line tool. Within every experiment the threshold for each channel was determined as the average of the mean pixel intensities of all cropped segments plus two standard deviations above the mean. Using this threshold, a binary mask including all pixels with intensity above the threshold was created for every channel. Puncta density was calculated as the number of triple co-localization between GFP fill, synaptic marker (typically either synapsin or bassoon) and protein of interest, divided by the length of the segment. Intensity of the protein of interest was measured as the average of the mean intensities measured under all the areas of a synaptic mask prepared from the combined binary images of GFP fill and synaptic marker. The intensity was normalized by the respective channel's threshold to combine results from several experiments. Characterization of PSD-95 mutants Images were quantified in a blinded manner using custom scripts for ImageJ. At least 6 images from a minimum of 3 different experiments (i.e., 3 different cultures) were taken for each condition. For each image, the total cell area was defined by a binary mask created from the GFP channel using the thresholding method described above. Synaptic areas encompass all pixels, where the total cell mask overlaps with a binary mask created from the synaptic marker channel (Shank, synapsin). The shaft area was produced by subtracting the synaptic marker mask from the total cell area. These binary masks were then used to measure the intensity of the RFP fluorescence in the respective areas. To estimate the relative RFP-PSD-95 expression levels of the individual PSD-95 mutants, mean RFP fluorescence was measured under the total area mask (total RFP) and normalized to total GFP. expression level = meanRFP total =meanGFP total The synaptic RFP intensity represents the mean RFP intensity under the synaptic mask normalized for expression levels by the mean GFP intensity under the total mask.
synaptic RFP intensity = meanRFP synaptic =meanGFP total The synaptic enrichment factor is calculated as the quotient of mean synaptic RFP and GFP intensity divided by the quotient of mean shaft RFP and GFP intensities.
synaptic enrichment factor = ðmeanRFP synaptic =meanGFP synaptic Þ=ðmeanRFP shaft =meanGFP shaft Þ Normalization with volume filler was omitted from the equations above for calculation of spine intensity and spine enrichment factor in Figure 6 because no channel was available for imaging a volume filler in the PSD-95 replacement experiments. Density and intensity of GluA1 EC , GluN1 total , GluA2 total , and a-actinin-1 staining was evaluated analogous to the analysis of a-actinin KD. Sholl analysis Epifluorescent images were analyzed in a blinded manner by drawing 6 circles with radii ranging from 20 mm to 120 mm around the soma using the ImageJ extension ConcentricCircles. The number of dendrites crossing each circle was counted manually using ImageJ's Cell Counter plugin. E213 and D217. As the direct interactions between E53 and K11, E213/D217 and K10 were confirmed by mutagenesis, they were set as unambiguous restraints for a second round of docking calculations together with the AIR from the first round. Docking calculation with HADDOCK generated 200 structures in a single cluster with RMSD of 0.5 Å of which the one with the lowest energy was selected for the model.
QUANTIFICATION AND STASTICAL ANALYSIS
All bar graphs are presented as the means ± SEM except Figure S6C (means ± SD). The sample size and statistical methods of each experiment is provided in the relevant figure legend. Significance is shown as *p < 0.05, **p < 0.01, ***p < 0.001.
